Position in ATYR
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$9,282
-$818 QoQ
Shares Held
11,900
-7.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $51,440,082 across 23 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
63,910 | $31,746,014 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
137,661 | $7,876,962 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,662 | $4,154,023 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
|
123,449 | $4,121,962 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
6,595 | $537,954 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
8,350 | $455,409 | |
| 7 | MRNA |
Moderna, Inc.
|
5,260 | $368,357 | |
| 8 | HURA |
TuHURA Biosciences, Inc./NV
|
156,519 | $366,254 |
All Filings in ATYR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,282 | 11,900 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $10,100 | 12,900 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $14,347 | 19,900 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $103,935 | 20,500 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $70,970 | 23,500 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||